Teva is committed to increasing access to high-quality healthcare for people across the globe, at every stage of life. We do this by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. The company’s line of generic and specialty treatments is backed by our impressive global development and manufacturing capabilities, ensuring the highest quality and accessibility to medicines while reducing costs. Teva’s participation in a wide range of therapeutic areas and dosage forms is empowered by a unique integration of innovative specialty and generic research. Some Facts and Figures Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. We rank among the 10 top pharmaceutical companies in the world and are active in 60 countries. 
Show more

Employee Rating

3.2
TypePublic
HQPetah Tikva, IL
Founded1901
Size (employees)51,792 (est)
Websitetevapharm.comwdxefcqufszuzezftuxetqsqxt
Teva Pharmaceuticals was founded in 1901 and is headquartered in Petah Tikva, IL
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Teva Pharmaceuticals

Richard Daniell

Richard Daniell

Executive Vice President, European Commercial
Kare Schultz

Kare Schultz

President & CEO
Iris Beck-Codner

Iris Beck-Codner

Executive Vice President, Global Brand & Communications
Hafrun Fridriksdottir

Hafrun Fridriksdottir

Executive Vice President, Global R&D
Michael Mike McClellan

Michael Mike McClellan

Executive Vice President, Chief Financial Officer
Carlo de Notaristefani

Carlo de Notaristefani

Executive Vice President, Global Operations
Show more

Teva Pharmaceuticals Office Locations

Teva Pharmaceuticals has an office in Petah Tikva
Petah Tikva, (HQ)
5 Basel St
Show all (1)
Report incorrect company information

Teva Pharmaceuticals Financials and Metrics

Teva Pharmaceuticals Revenue

Market capitalization (4-Dec-2018)

20.9b

Closing stock price (4-Dec-2018)

20.6
Teva Pharmaceuticals's current market capitalization is $20.9 b.
Show all financial metrics

Teva Pharmaceuticals Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Labrys BiologicsJune 03, 2014$825 m
Report incorrect company information

Teva Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information

Teva Pharmaceuticals News and Updates

Global Topical Contraceptive Market Segmented by Application and Geography Trends, Growth and Forecasts to 2025 | ALLERGAN, Mylan, Merck Millipore, Pfizer, and Teva Pharmaceuticals

They have worked carefully with administration bodies, exchange partnerships, news and magazine bodies, and furthermore with different bodies related to the Topical Contraceptive Market Posted via Industry Today. Follow us on Twitter @IndustryToday

Cancer Pain Therapeutics Market Global Overview, Segmentation & Competitive Landscape by Focusing On Top Key Vendors: BioDelivery Sciences, ProStrakan Group, Teva Pharmaceuticals, Yamaha

The Global Cancer Pain Therapeutics Market Report includes a comprehensive analysis of the present market. The report starts with the basic Cancer Pain Therapeutics Market overview and then goes into each and every detail. Posted via Industry Today. Follow us on Twitter @IndustryToday

Glaucoma Pharmaceutical 2018 Global Market Key Players – Pfizer, Merck, Allergan, Santen, Alcon, Teva Pharmaceuticals, Fera Pharmaceuticals – Analysis and Forecast to 2025

WiseGuyRerports.com Presents “Global Glaucoma Pharmaceutical Market Size, Status and Forecast 2018-2025” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Primary Sclerosing Cholangitis Treatment Market 2018-2022: Key Vendors are Allergan, Glenmark, Impax Laboratories, Mylan & Teva Pharmaceuticals

DUBLIN, Sept 11, 2018 /PRNewswire/ -- The "Global Primary Sclerosing Cholangitis Treatment Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Primary Sclerosing Cholangitis Treatment Market to grow at a CAGR of 3.57% during the period 2018-2022....

Small Molecular API Market Notable Progress to Be Witnessed | Pharmaceutical Industry | Leading Players Teva Pharmaceuticals limited, Sun Pharmaceuticals Industries, Boehringer Ingelheim | Forecast up to 2027

Small Molecule API Market information presented through Market Scenario, Growth Overview, Geographical Analysis and Topmost Players spread over 110 pages. Avail the in-depth table of content (TOC) & market synopsis on MarketResearchFuture.com – Forecast till 2027. Posted via Industry Today. Foll…
Report incorrect company information

Teva Pharmaceuticals Company Life and Culture

Report incorrect company information

Teva Pharmaceuticals Frequently Asked Questions

  • When was Teva Pharmaceuticals founded?

    Teva Pharmaceuticals was founded in 1901.

  • Who are Teva Pharmaceuticals key executives?

    Teva Pharmaceuticals's key executives are Richard Daniell, Kare Schultz and Iris Beck-Codner.

  • How many employees does Teva Pharmaceuticals have?

    Teva Pharmaceuticals has 51,792 employees.

  • Who are Teva Pharmaceuticals competitors?

    Competitors of Teva Pharmaceuticals include STERIS, Perrigo and BioDelivery Sciences International.

  • Where is Teva Pharmaceuticals headquarters?

    Teva Pharmaceuticals headquarters is located at 5 Basel St, Petah Tikva.

  • Where are Teva Pharmaceuticals offices?

    Teva Pharmaceuticals has an office in Petah Tikva.

  • How many offices does Teva Pharmaceuticals have?

    Teva Pharmaceuticals has 1 office.